Human Defensin-5/HD5 [E21R]

General Information


DRACP ID  DRACP03857

Peptide Name   Human Defensin-5/HD5 [E21R]

Sequence  ATCYCRTGRCATRESLSGVCRISGRLYRLCCR

Sequence Length  32

UniProt ID  Q01523 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral



Structure Information


PDB ID  4RBX 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C145H249N53O43S6

Absent amino acids  DFHKMNPQW

Common amino acids  R

Mass  416838

Pl  9.19

Basic residues  7

Acidic residues  1

Hydrophobic residues  7

Net charge  6

Boman Index  -9160

Hydrophobicity  -14.38

Aliphatic Index  64.06

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  3355

Absorbance 280nm  108.23

Polar residues  17

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23269800

Title  Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites

Doi Not available

Year  2013

Literature 2

Pubmed ID 25782105

Title  Design of a potent antibiotic peptide based on the active region of human defensin 5

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13710

DRACP is developed by Dr.Zheng's team.